HighVista Strategies’s Rocket Pharmaceuticals RCKT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q2 | – | Sell |
-48,191
| Closed | -$764K | – | 114 |
|
|
2022
Q1 | $764K | Buy |
48,191
+1,278
| +3% | +$20.3K | 0.49% | 60 |
|
|
2021
Q4 | $1.02M | Buy |
46,913
+6,242
| +15% | +$136K | 0.82% | 45 |
|
|
2021
Q3 | $1.22M | Buy |
40,671
+22,247
| +121% | +$665K | 0.8% | 35 |
|
|
2021
Q2 | $816K | Buy |
18,424
+4,088
| +29% | +$181K | 0.58% | 39 |
|
|
2021
Q1 | $636K | Sell |
14,336
-10,231
| -42% | -$454K | 0.47% | 54 |
|
|
2020
Q4 | $1.35M | Buy |
24,567
+7,225
| +42% | +$396K | 0.86% | 21 |
|
|
2020
Q3 | $396K | Sell |
17,342
-7,682
| -31% | -$175K | 0.29% | 66 |
|
|
2020
Q2 | $524K | Buy |
+25,024
| New | +$524K | 0.43% | 20 |
|